Welcome to The Advance, the newsletter of the CCA. Want to help us promote evidence-informed policy in the public interest? Feel free to forward this newsletter to a friend or colleague. If you haven’t subscribed yet, you can sign up here. Le français suit.
IN THIS EDITION:
In September 2016, the United Nations (UN) declared antimicrobial resistance (AMR) “a fundamental, long-term threat to human health, sustainable food production, and development.” News reports featured dire estimates: “By 2050, drug resistance will kill more people each year than cancer and cost the world as much as $100 trillion in lost economic output,” an Associated Press story noted. At the time, no such estimates existed for Canada.
Following the UN announcement, the Public Health Agency of Canada asked the CCA to examine the socioeconomic impacts of antimicrobial resistance in Canada. In late 2019, the CCA released When Antibiotics Fail, a 237-page report from its Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada. When Antibiotics Fail includes a quantitative economic model to explore the relationships between AMR, health, labour productivity, agriculture, and trade. Projections from this model, the panel noted, “are the first of their kind in Canada, and provide policy-makers and other stakeholders with credible estimates of the potential magnitude of AMR impacts over the next three decades.” Those estimates, noted Eric Meslin, CCA’s former president, “are alarming, and provide evidence to support decision-making.”
Ahead of the September 26 UN General Assembly high-level meeting on AMR, the CCA revisited When Antibiotics Fail and spoke with several of the experts who authored it. The report, says B. Brett Finlay, the panel’s chair, “makes a great point about the cost of doing nothing.”
Click here to explore our impact report for When Antibiotics Fail.